ARID1B expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.90769988484396E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.13159999999935E-05 |
Normal-vs-Stage2 |
1.337020E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.005900E-02 |
Stage1-vs-Stage2 |
9.898800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.946800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
5.541800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.49340000155496E-08 |
Normal-vs-AfricanAmerican |
1.691030E-01 |
Normal-vs-Asian |
2.599700E-02 |
Caucasian-vs-AfricanAmerican |
1.399560E-01 |
Caucasian-vs-Asian |
5.423800E-01 |
AfricanAmerican-vs-Asian |
2.959200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.8400000000034E-05 |
Normal-vs-Female |
1.51522999999321E-05 |
Male-vs-Female |
9.303800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.730350E-02 |
Normal-vs-Extreme_Weight |
3.041400E-04 |
Normal-vs-Obese |
3.196900E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.231800E-01 |
Normal_Weight-vs-Obese |
5.511600E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.007410E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.44940000001981E-08 |
Normal-vs-Age(41-60Yrs) |
3.959200E-03 |
Normal-vs-Age(61-80Yrs) |
2.23310000002641E-06 |
Normal-vs-Age(81-100Yrs) |
2.852000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.790800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.511200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.641600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.856800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.597800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.043200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.293200E-01 |
Normal-vs-Grade 3 |
5.865800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.711800E-01 |
Grade 2-vs-Grade 4 |
7.293200E-01 |
Grade 3-vs-Grade 4 |
5.865800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.48229999946881E-07 |
Normal-vs-N1 |
1.127800E-02 |
N0-vs-N1 |
4.441700E-02 |
|
|